• Wanpen Chaicumpa: Center of Excellence on Therapeutic Proteins and Antibody Engineering, Faculty of Medicine Siriraj Hospital, Mahidol University (Bangkok, TH) (viral infection, antibody therapy and autophagy);
  • Eugenia Dogliotti: Istituto Superiore di Sanità, Roma (autophagy, DNA damage, skeletal muscle differentiation);
  • Danny Dhanasekaran: Stephenson Cancer Center, University of Oklahoma  Health Science Center, Oklahoma City (OK 73104, US) (Long Non Coding RNA and epigenetic regulation of autophagy in ovarian cancer);
  • Benjamin K. Tsang: Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, and Interdisciplinary School of Health Sciences, University of Ottawa (Canada) (autophagy and ovary polycystic syndrome);
  • Gwenal Rolin and Philippe Humbert: Département de Dermatologie et Centre d’Investigation Clinique, Université de la Franche-Comté, Besançon (France) (autophagy and cheloids);
  • Paul Saftig: Unit of Molecular Cell Biology and Transgenic Research, Institute of Biochemistry, Medical Faculty, University of Kiel, Germany (Cathepsin D and lysosomal storage diseases);
  • John McDonald: «Integrative Cancer Research Center of the Georgia Institute of Technology», Georgia Tech University, Georgia (Atlanta, US) (autophagy and ovarian cancer stem cells);
  • Hans Baeumler: Institute of Transfusion Medicine, Berlin-Brandenburg Center for Regenerative Therapies, Charité – Universitätsmedizin Berlin (Germany) (nanotheranostics, in cell imaging);
  • Lorenzo Tei and Mauro Botta: Dipartimento di Scienze e innovazione Tecnologica, Università del Piemonte Orientale (Alessandria, Italy) (nanotheranostics, in cell imaging);
  • Prasert Sobhon: Faculty of Sciences, Mahidol University (Bangkok, TH) (autophagy and prawns reproduction);
  • Chanitra Tuwajit and Peti Tuwajit: Siriraj Hospital Medical School, Mahidol University (Bangkok, TH), (autophagy and cancer associated fibroblasts in ovarian cancer);
  • Puangrat Yongvanit and Nisana Namwat: Khon Kaen Center of Excellence for Cholangiocarcinoma (Khon Kaen, TH), (autophagy and cholanagiocarcinoma);
  • Xin Zhang:  Stephenson Cancer Center and Department of Physiology, University of Oklahoma Health Science Center, Oklahoma City (OK 73104, US), (role of metastasis suppressor CD82 in the regulation of autophagy in prostate cancer).




  • Tewin Tencomnao: Faculty of Allied Health Sciences, Chulalongkorn University, Thailand, (autofagia e UVB skin carcinogenesis);
  • Bonnie F. Sloane: Department of Pharmacology della Wayne State University di Detroit, USA (Biogenesis and function of lysosomal Cathepsins);
  • David Murphy and Henry Wellcome: Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Gran Bretagna (autophagy and neurodegenerative diseases)
  • Andrej Hasilik: Institute fuer Physiologische Chemie, Klinikum der Philipps-Universitaet Marburg, Germany (Biogenesis and function of lysosomal Cathepsins);
  • Michelle Ollivier: INRA Unité Génomique et Physiologie de la Lactation, Jouy-en-Josas, CEDEX, France (Role of Cathepsin D in mammary gland physiology);
  • Duncan Smith: Insitute of Molecular Biology and genetics, Mahidol University, Bangkok, Thailand (Autophagy and Dengue virus infection)
  • Tamara Lah: National Institute of Biology, Ljubljana, Slovenia, (Cathepsins and glioblastomas);
  • Francesco Fornai: Università di Pisa, Italy (Autophagy and neurodegeneration);
  • Salvatore Coluccia: Dipartimento di Chimica, Università di Torino, Italy (Nanotheranostics, in cell imaging)
  • Emanuele Albano and Rita Carini: Dipartimento di Scienze della Salute, Università del Piemonte Orientale di Novara, Italy (lysosome and hepatocyte preconditioning)
  • Guido Valente: Laboratorio di Anatomia Patologica, Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale di Novara, Italy (cancer biomarkers)
%d blogger hanno fatto clic su Mi Piace per questo: